p38 MAPK: A mediator of hypoxia-induced cerebrovascular inflammation

Journal of Alzheimer's Disease

Volumn 32, Issue 3, 2012, Pages 587-597

  Sanchez, Alma ^a   Tripathy, Debjani ^a   Yin, Xiangling ^a   Desobry, Katheryn ^a   Martinez, Joseph ^a   Riley, Jarred ^a   Gay, Dylan ^a   Luo, Jinau ^a   Grammas, Paula ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Alzheimer's disease; cerebrovascular; COX 2; hypoxia; inflammation; iNOS; p38 MAPK

Indexed keywords

ANGIOPOIETIN 2; CYCLOOXYGENASE 2; GELATINASE A; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; CEREBROVASCULAR INFLAMMATION; CONTROLLED STUDY; ENCEPHALITIS; ENDOTHELIUM CELL; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; UPREGULATION; VASCULITIS; WESTERN BLOTTING;

EID: 84872246867     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120829     Document Type: Article

References (59)

1. Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E (2011) alzheimer's disease. Lancet 377, 1019-1031.
2. de la Torre JC, Mussivand T (1993) Can a disturbed brain microcirculation cause alzheimer's disease? Neurol Res 15, 146-153. (Pubitemid 23166998)
3. Zlokovic BV (2005) Neurovascular mechanisms of alzheimer's neurodegeneration. Trends Neurosci 28, 202-208.
4. Kalaria RN (2010) Vascular basis for brain degeneration: Faltering controls and risk factors for dementia. Nutr Rev 68, S74-S87.
5. Knopman DS, Roberts R (2010) Vascular risk factors: Imaging and neuropathologic correlates. J alzheimer Dis 20, 699-709.
6. Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: Implications for alzheimer's disease. J Neuroinflammation 8, 26.
7. Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T (2008) Altered morphology and 3D architecture of brain vasculature in a mouse model for alzheimer's disease. Proc Natl Acad Sci U S A 105, 3587-3592. (Pubitemid 351723596)
8. Iadecola C (2004) Neurovascular regulation in the normal brain and in alzheimer's disease. Nat Rev Neurosci 5, 347360.
9. Zlokovic BV (2008) The blood-Brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
10. Zuliani G, Cavalieri M, Galvani M, Passaro A, Munari MR, Bosi C, Zurlo A, Fellin R (2008) Markers of endothelial dysfunction in older subjects with late onset alzheimer's disease or vascular dementia. J Neurol Sci 272, 164-170.
11. de la Torre JC (2006) Howdo heart disease and stroke become risk factors for alzheimer's disease? Neurol Res 28, 637-644. (Pubitemid 44433323)
12. Ogunshola OO, Antoniou X (2009) Contribution of hypoxia to alzheimer's disease: Is HIF-1alpha a mediator of neurodegeneration? Cell Mol Life Sci 66, 3555-3563.
13. Peers C, Dallas ML, Boycott HE, Scragg JL, Pearson HA, Boyle JP (2009) Hypoxia and neurodegeneration. Ann N Y Acad Sci 1177, 169-177.
14. Zhang X, Le W (2010) Pathological role of hypoxia in alzheimer's disease. Exp Neurol 223, 299-303.
15. Kalaria RN, Bhatti SU, Palatinsky EA, Pennington DH, Shelton ER, Chan HW, Perry G (1993) Accumulation of the beta amyloid precursor protein at sites of ischemic injury in rat brain. Neuroreport 4, 211-214. (Pubitemid 23080879)
16. Ueno M, Tomimoto H, Akiguchi I, Wakita H, Sakamoto H (2002) Blood-Brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 22, 97-104. (Pubitemid 34038388)
17. Chen GJ, Xu J, Lahousse SA, Caggiano NL, de la Monte SM (2003) Transient hypoxia causes Alzheimer-Type molecular and biochemical abnormalities in cortical neurons: Potential strategies for neuroprotection. J Alzheimers Dis 5, 209228.
18. Pugh CW, Ratcliffe PJ (2003) Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 9, 677-684. (Pubitemid 36749216)
19. Nilsson I, Shibuya M,Wennström (2004) Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res 299, 476-485. (Pubitemid 39179813)
20. Grammas P,TripathyD, Sanchez A,YinX, Luo J (2011) Brain microvasculature and hypoxia-Related proteins in alzheimer's disease. Int J Clin Exp Pathol 4, 616-627.
21. Cummins EP, Taylor CT (2005) Hypoxia-Responsive transcription factors. Pflugers Arch 450, 363-371. (Pubitemid 41380694)
22. Munoz L, Ammit AJ (2010) Targeting p38 pathway for the treatment of alzheimer's disease. Neuropharmacology 58, 561-568.
23. Schett G, Zwerina J, Firestein G (2008) The p38 mitogenactivated protein kinase (MAPK) pathway in rheumatoid arthritis. Ann Rheum Dis 67, 909-916. (Pubitemid 351956650)
24. Schindler JF, Monahan JB, Smith WG (2007) p38 pathway kinases as anti-inflammatory drug targets. J Dent Res 86, 800811.
25. Sun A, Liu M, Nguyen XV, Bing G (2003) p38 MAP kinase is activated at early stages in alzheimer's disease brain. Exp Neurol 183, 394-440.
26. Ferrer I (2004) Stress kinases involved in tau phosphorylation in alzheimer's disease, tauopathies and APP transgenic mice. Neurotox Res 6, 469-475.
27. Munoz L, Ranaivo HR, Roy SM, HuW, Craft JM, McNamara LK, Chico LW, Van Eldik LJ, Watterson DM (2007) A novel p38 MAPK inhibitor suppresses brain proinflammatory cytokine up-Regulation and attenuates synaptic dysfunction and behavioral deficits in an alzheimer's disease mouse model. J Neuroinflammation 4, 21.
28. Liu L, Aboud O, Jones RA, Mrak RE, Griffin WS, Barger SW (2011) Apolipoprotein E expression is elevated by interleukin 1 and other interleukin 1-induced factors. J Neuroinflammation 8, 175.
29. Kim SH, Smith CJ,Van Eldik LJ (2004) Importance ofMAPK pathways for microglial pro-inflammatory cytokine IL-1 beta production. Neurobiol Aging 25, 431-439. (Pubitemid 38317340)
30. Ball MJ, Griffin-Brooks S, MacGregor JA, Nagy B, OjalvoRose E, Fewster PH (1988) Neuropathological definition of alzheimer disease: Multivariate analyses in the morphometric distinction between alzheimer dementia and normal aging. alzheimer Dis Assoc Disord 2, 29-37.
31. Khachaturian ZS (1985) Diagnosis of alzheimer's disease. Arch Neurol 42, 1097-1105.
32. Grammas P, Moore P, Weigel PH (1999) Microvessels from alzheimer's disease brains kill neurons in vitro. Am J Pathol 154, 337-342. (Pubitemid 29094084)
33. Diglio CA, LiuW, Grammas P, Giacomelli F,Wiener J (1993) Isolation and characterization of cerebral resistance vessel endothelium in culture. Tissue Cell 25, 833-846. (Pubitemid 24025814)
34. Davidson SM, DuchenMR(2007) Endothelial mitochondria: Contributing to vascular function and disease. Circ Res 100, 1128-1141. (Pubitemid 46684126)
35. Grammas P, Samany PG, Thirumangalakudi L (2006) Thrombin and inflammatory proteins are elevated in alzheimer's disease microvessels: Implications for disease pathogenesis. J Alzheimers Dis 9, 51-58.
36. Brahimi-Horn MC, Pouyssegur J (2009) HIF at a glance. J Cell Sci 122, 1055-1057.
37. Taylor CT, Colgan SP (2007) Hypoxia and gastrointestinal disease. J Mol Med (Berl) 85, 1295-1300. (Pubitemid 50004090)
38. Fraisl P, Aragones J, Carmeliet P (2009) Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease. Nat Rev Drug Discov 8, 139-152.
39. Grammas P, Ovase R (2002) Cerebrovascular transforming growth factor-Beta contributes to inflammation in the alzheimer's disease brain. Am J Pathol 160, 1583-1587. (Pubitemid 34525638)
40. Thirumangalakudi L, Samany PG, Owoso A, Wiskar B, Grammas P (2006) Angiogenic proteins are expressed by brain blood vessels in alzheimer's disease. J Alzheimers Dis 10, 111-118. (Pubitemid 44401371)
41. Grammas P,OvaseR(2001) Inflammatory factors are elevated in brain microvessels in alzheimer's disease. Neurobiol Aging 22, 837-842. (Pubitemid 34066550)
42. KarinM(2005) Inflammation-Activated protein kinases as targets for drug development. Proc Am Thorac Soc 2, 386-390; discussion 394-385. (Pubitemid 41699701)
43. Kumar S, Boehm J, Lee JC (2003) p38 MAP kinases: Key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2, 717-726. (Pubitemid 37361787)
44. YamadaT, Egashira N, Bando A, NishimeY,TonogaiY, Imuta M,Yano T, OishiR(2012) Activation of p38MAPKby oxidative stress underlying epirubicin-induced vascular endothelial cell injury. Free Radic Biol Med 52, 1285-1293.
45. Adachi T, Teramachi M, Yasuda H, Kamiya T, Hara H (2012) Contribution of p38 MAPK, NF-?B and glucocorticoid signaling pathways to ER stress-induced increase in retinal endothelial permeability. Arch Biochem Biophys 520, 30-35.
46. Lee SR, Lo EH (2003) Interactions between p38 mitogenactivated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-Reoxygenation. Stroke 34, 27042709. (Pubitemid 37392771)
47. Ohta T, Eguchi R, Suzuki A, Miyakaze S, Ayuzawa R, Kaji K (2007) Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells. J Cell Physiol 211, 673-681. (Pubitemid 46683035)
48. Zhang CL, Song F, Zhang J, Song QH (2010) Hypoxiainduced Bcl-2 expression in endothelial cells via p38 MAPK pathway. Biochem Biophys Res Commun 394, 976-980.
49. Jung F, Palmer LA, Zhou N, Johns RA (2000) Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ Res 86, 319-325. (Pubitemid 30108826)
50. Matrone C, Pignataro G, Molinaro P, Irace C, Scorziello A, Di Renzo GF, Annunziato L (2004) HIF-1alpha reveals a binding activity to the promoter of iNOS gene after permanent middle cerebral artery occlusion. J Neurochem 90, 368-378. (Pubitemid 38938223)
51. Ptasinska A,Wang S, Zhang J,Wesley RA, Danner RL (2007) Nitric oxide activation of peroxisome proliferator-Activated receptor gamma through a p38 MAPK signaling pathway. FASEB J 21, 950-961. (Pubitemid 46348267)
52. ChenY, ArataniY, Osawa T, Fukuyama N, Tsuji C, Nakazawa H (2008) Activation of inducible nitric oxide synthase increases MMP-2 and MMP-9 levels in ApoE-knockout mice. Tokai J Exp Clin Med 33, 28-34.
53. Milkiewicz M, Kelland C, Colgan S, Haas TL (2006) Nitric oxide and p38 MAP kinase mediate shear stress-Dependent inhibition of MMP-2 production in microvascular endothelial cells. J Cell Physiol 208, 229-237. (Pubitemid 43849009)
54. Davis JS, Yeo TW, Piera KA, Woodberry T, Celermajer DA, Stephens DP, Anstey NM(2010) Angiopoietin-2 is increased in sepsis and inversely associated with nitric oxide-Dependent microvascular reactivity. Crit Care 14, R89.
55. Pacher P, Beckman JS, Liaudet L (2007) Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87, 315-424. (Pubitemid 46217686)
56. Dorheim MA, Tracey WR, Pollack JS, Grammas P (1994) Nitric oxide synthase activity is elevated in brain microvessels in alzheimer's disease. Biochem Biophys Res Commun 205, 659-665. (Pubitemid 24381677)
57. Zulueta JJ, Sawhney R, Kayyali U, Fogel M, Donaldson C, Huang H, Lanzillo JJ, Hassoun PM (2002) Modulation of inducible nitric oxide synthase by hypoxia in pulmonary artery endothelial cells. Am J Respir Cell Mol Biol 26, 22-30. (Pubitemid 34029817)
58. Kan WH, Yan WS, Jiang Y, Wang JZ, Qin QH, Zhao KS (2002) Role of p38 mitogen-Activated protein kinase in lipopolysaccharide-induced expression of inducible nitric oxide synthase in human endothelial cells. Di Yi Jun Yi Da Xue Xue Bao 22, 388-392.
59. Huang H, Rose JL, Hoyt DG (2004) p38 Mitogenactivated protein kinase mediates synergistic induction of inducible nitric-oxide synthase by lipopolysaccharide and interferon-gamma through signal transducer and activator of transcription 1 Ser727 phosphorylation in murine aortic endothelial cells. Mol Pharmacol 66, 302-311. (Pubitemid 38989487)